Search Immortality Topics:

Page 7«..6789..2030..»


Category Archives: Longevity

7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market – InvestorPlace

While it doesnt seem like it when youre young, aging happens to everyone and therefore, so-called AgeTech stocks should benefit from inevitability. A buzzword for age-related technology, this concept refers to a rapidly growing field focused on developing and applying innovative solutions to improve the lives of senior citizens. The segment encompasses the full range of aging needs, from maintaining health to enhancing independence.

Fundamentally, these longevity stocks benefit from simple math. As an AP report noted last year, America aged rapidly as baby boomers grew older and births dropped. And that came about because when the baby boomer generation was born, the cohort represented a swarm of new humanity as the U.S. entered a post-war resurgence. However, as with anything in life, there is an ebb and flow.

Thanks to the rise in medical and therapeutic technologies, people have the opportunity to live longer than ever. Logically, that will impact society for years to come. At least from a narrative standpoint, these AgeTech stocks should command longstanding relevance.

Source: Ken Wolter / Shutterstock.com

Ordinarily, youd think of Best Buy (NYSE:BBY) as one of the top retail enterprises, not an AgeTech stock. However, its been moving into the senior care realm. Last year, the companys Best Buy Health unit which seeks to enrich lives through technology updated its Lively plan to better help seniors stay connected, safe, and healthy.

For a subscription fee, Best Buy connects its senior users with a knowledgeable, caring team to address urgent matters, day or night. Just based on current trends, demand for such services could rise. According to a Pew Research Center report in November 2020, the pace of boomer retirements accelerated versus the prior year. Such a dynamic will continue to exacerbate for lack of a better word for years to come.

Of course, longevity stocks can be a tricky element because of the niche focus. Fortunately, Best Buy is a diversified retailer, serving multiple consumer needs. Better yet, shares are available at a discount, trading at just under 12X forward earnings. If you want an AgeTech stock you can trust, BBY seems a reasonable deal.

Source: sylv1rob1 / Shutterstock.com

At first glance, Apple (NASDAQ:AAPL) doesnt seem the most compelling example of AgeTech stocks. After all, the companys products tend to cater to the hipper, younger audience you know, the kind that are glued to its smart devices. However, Apples versatility makes it an excellent candidate among longevity stocks. As well, its ubiquity doesnt hurt one bit.

For one thing, Apple has dove headfirst into the consumer wearable technology market. True, that doesnt necessarily translate to direct relevance regarding AgeTech stocks. However, the Apple Watch features a fall detection feature, which can automatically connect the unfortunate user to emergency services if needed. Further, for years, the tech juggernaut has incorporated emergency SOS services into its iPhones. Thats useful for anyone in need, especially senior citizens.

Further, a report came out that a doctor was able to save a plane passengers life using an Apple Watch borrowed from a flight attendant. That just goes to show you how powerful these smart devices are. If youre looking for a viable AgeTech stock, AAPL should be on your must-have list.

Source: The Art of Pics / Shutterstock.com

A multinational technology corporation, Microsoft (NASDAQ:MSFT) also doesnt immediately resonate as an AgeTech stock. Instead, the company is well known for its software, especially its Microsoft Office suite of word processors, spreadsheets and other necessities of white-collar life. Also, the company dominates in the desktop operating system arena. If youre not fluent in Microsoft, youre not getting very far in this modern ecosystem.

That said, Microsoft isnt only about spreadsheets and Xboxes. For example, the company offers accessibility tools for mental health, including people who suffer from bipolar disorder, anxiety, post-traumatic stress disorder (PTSD) or depression. Although mental health risks arent exclusively a phenomenon impacting seniors, its important to note their vulnerability. Per the World Health Organization, loneliness and social isolation represent risks in later life.

As well, Microsofts latest operating system upgrade features options such as larger text, voice control and simplified interfaces. Combine that with its stout financials and MSFT easily ranks among the top AgeTech stocks. Analysts also rate shares a unanimous strong buy (among 35 expert voices).

Source: Postmodern Studio / Shutterstock.com

Based on price action, Teladoc (NYSE:TDOC) shares incurred a rags-to-riches-back-to-rags tale and its no surprise why. Back during the worst of the Covid-19 disaster, Teladoc which offered telehealth services commanded obvious relevance. During that time, no one wanted to be around other people. With telehealth, patients could interact with their doctors in the privacy of their own homes.

However, with the fading of fears of the SARS-Cov-2 virus came a quick erosion of TDOC. Once a bright prospect among longevity stocks, Teladoc struggled for traction. Even now, its trailing 52-week performance leaves much room for improvement. Nevertheless, dont be surprised if TDOC makes a second comeback. Notably, its short interest stands at 14% of its float, which is quite elevated, begging for a contrarian response.

As for its relevance as an AgeTech stock, seniors may see reduced mobility; for example, many may lose their ability to drive. Naturally, such an obstacle would crimp in-person medical visits. However, Teladoc could easily bridge the gap, providing care at the source. Thus, it makes a strong case for longevity stocks.

Source: Sundry Photography/Shutterstock.com

A multinational medical devices and healthcare company, Abbott Laboratories (NYSE:ABT) offers effectively permanent relevance. Regarding its core business, Abbott may be best known recently for its diabetes management system known as FreeStyle Libre. Featuring a discreet profile with accurate readings, Libre also does away with fingersticks, which can cause pain or discomfort.

Now, (type 2) diabetes is not exclusively a problem for seniors. However, according to the Mayo Clinic, the risk of this condition materializing increases with age, especially after 35 years. Therefore, seniors fall into a clear risk category, making ABT a pertinent Agetech stock. Also, Abbott invests heavily in artificial-intelligence-powered diagnostics and personalized medicine approaches. Both can lead to early disease detection, which is particularly important for aging populations.

Plus, Abbott has a clear advantage over many other AgeTech stocks thanks to its reliable passive income. Currently, its forward yield is 1.99%, which isnt that impressive. However, the company has increased its payout consecutively across 52 years. That most certainly is impressive and so is its strong buy rating with a $125.70 price target.

Source: Piotr Swat / Shutterstock

Based in Bloomfield, Connecticut, Cigna (NYSE:CI) is a for-profit multinational managed healthcare and insurance firm. According to its corporate profile, Cignas insurance subsidiaries represent major providers of medical, dental, disability, life, and accident insurance and related products and services. To be sure, investors probably wont get rich off of CI stock. Rather, its a slow-and-steady mechanism to build wealth.

Fundamentally, Cigna ranks among the AgeTech stocks due to its Medicare Advantage plans, which include innovative benefits such as telehealth access, chronic disease management programs, and in-home care services. All of these services should resonate with seniors and their unique challenges. Also, Cigna approaches the aging population in a holistic sense, partnering with other organizations to provide mental health support for older adults and other vulnerable populations.

Moving onto the financials, Cigna doesnt exactly have standout statistics other than its consistent profitability. However, it keeps the boat afloat with very few fiscal concerns. As a bonus, CI trades at a forward earnings multiple of 10.76X, lower than the sector median 12.77X. Thus, its an intriguing AgeTech stock.

Source: Ivan Chudakov / Shutterstock.com

Coming to the last idea for AgeTech stocks, Im going to end on a speculative note. Ive discussed ReWalk Robotics (NASDAQ:RWLK) before, which develops and markets exoskeletons that help individuals with spinal cord injuries regain walking ability. Its a fascinating enterprise, which offers hope for many mobility-challenged individuals.

Looking at its website, the company appears to focus on restoring functionalities for people who have suffered injury or physical trauma (i.e. wounded veterans). However, ReWalk also offers the ReStore Soft Exo-Suit, which represents a revolution in post-stroke gait training. Essentially, the platform facilitates rehabilitation for people with lower limb disability due to the effects of a stroke. And yes age is definitely a factor when assessing stroke risk.

As exciting as ReWalks exoskeleton business is, we have to be honest with each other: RWLK is incredibly treacherous. Over the trailing month, it has danced around the demarcation point separating the literal and metaphorical definition of penny stocks. It also features a market capitalization thats barely above the nano-cap threshold.

Still, if youre willing to take risks with your AgeTech stocks, RWLK should be on your radar.

On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.The opinions expressed in this article are those of the writer, subject to the InvestorPlace.comPublishing Guidelines.

A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.

Visit link:
7 'AgeTech' Stocks to Profit From the Booming Longevity Market - InvestorPlace

Posted in Longevity | Comments Off on 7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market – InvestorPlace

4 Launch Strategies for Startup Success and Longevity – Entrepreneur

Opinions expressed by Entrepreneur contributors are their own.

The startup scene across the United States is expanding at almost unprecedented rates. Data from the Economic Innovation Group (EIG) shows that the country's business startup rate in 2021 was the highest since the Great Recession. This statistic alone illustrates two facts: founders are confident in the opportunities in the U.S. economy, and the startup marketplace is growing more crowded in almost every industry.

As a result, founders are turning to more innovative approaches to ensure their product launches stand out from the crowd, becoming both memorable and financially successful.

The United States has traditionally been a hotbed for startup activity. With a culture that embraces entrepreneurship and values business growth, the country has traditionally welcomed new ideas and innovation.

However, having a great idea is no longer enough to succeed. With nearly half a million new businesses being created every year, it can be hard for founders to cut through the noise to get the attention of investors and potential early customers and launch their first product. Some of the most successful recent launches have seen business owners turn to innovative and unconventional tactics to help them stand out in their marketplace.

Although common challenges vary depending on which industry a startup is in, some apply to almost any startup. Most have to work with limited resources regarding manpower and finances. New companies also need to overcome lower brand recognition levels than their more established counterparts, making it harder to stand out.

Product launches can be divided into three phases: pre-launch, launch, and post-launch. Applying an innovative approach can be beneficial at either of these stages, and it will depend on your industry to determine when it is most beneficial to think and act out of the box.

Related: 3 Things Your Business Idea Must Have To Succeed as Proven By Famous Harvard Business School Startups

Think of a music festival: for hours and sometimes days, lesser-known bands are taking the stage, building up to the main event, the headliner. As these bands play, the crowd's excitement grows, and they are ready to cheer as loud as they can for the main artist. The previous bands have helped to create a buzz around what is coming next.

The same process happens when your startup is getting ready to launch a new product. In the pre-launch phase, your team is looking to build excitement and anticipation that turns into endorsement and sales once your product is ready. Teaser campaigns can work well to build excitement, or your team could leverage your social media channels to build a community around the upcoming product. Just like the crowds at the festival, engaging with the community will help build buzz.

Stock trading app Robinhood is a great example of a successful pre-launch strategy. Well before the app was launched, the founders attracted over a million users. They used a compelling proposition $0 commission on trades and a referral marketing strategy to build buzz. Signing up was simple, and any new user had the right to invite others. The more people a user invited, the higher they moved up in the queue to gain access to the app. By the time the product launched, a community of traders was waiting to use it.

Working with influencers and celebrities and building partnerships with complementary brands can be powerful tools during the pre-launch and launch phases. The influencer's notoriety and their community can become multipliers for marketing messages, and they may also be among your first customers.

Direct-to-consumer beauty company Glossier has been using a novel approach to influencer marketing for its product launches. Rather than working with established influencers, the company sends products to people who engage a lot with its online content or have bought a high volume of products. These ambassadors then share their thoughts and help spread the word about new products.

Related: 5 Things You Should Know Before Collaborating With An Influencer

Launch events offer startups another excellent opportunity to connect with their audiences. While the classic, opening-night-style event may work for brick-and-mortar startups, tech businesses can still utilize this strategy to lift the proverbial curtain on a product.

Virtual tours and other experiences work well for launch events, especially if they allow the audience to interact with the product. Consider using the pre-launch phase to deliver clues about the product, allowing your audience to build a connection. The launch then becomes the final step that reveals the product and perhaps offers free access to those who have consistently engaged during the pre-launch phase.

It is too easy to pour all your energy into the launch and pre-launch phase but forget about post-launch engagement. Doing that would mean your company is missing out on one of its biggest opportunities.

The post-launch phase is when you turn first-time customers into advocates. This is the perfect time to ask for feedback and show your customers you care by resolving problems quickly. It is also important to keep an open mind toward product iterations and adjustments during this phase. No matter how much time your team spent developing your product, it is almost impossible to foresee every potential issue.

Dealing with concerns quickly and engaging customers regularly will go a long way toward building a loyal customer base for your brand.

Related: Redefining Customer Engagement in a World Where Data Privacy Reigns

Innovative product launches make an impression, with consumers buying your product immediately and others holding off. Taking a creative approach to the pre-launch, launch, and post-launch phases can help startups build the foundations of a loyal customer base that has supported the brand for decades.

There is no right or wrong way of applying these out-of-the-box approaches. Draw inspiration from the examples above, but remember to develop a launch strategy that is authentic to your startup for the highest impact.

Read more:
4 Launch Strategies for Startup Success and Longevity - Entrepreneur

Posted in Longevity | Comments Off on 4 Launch Strategies for Startup Success and Longevity – Entrepreneur

The Melis Siblings: A Longevity Tale Rooted in Diet – BNN Breaking

The Melis Siblings Dietary Secrets to Longevity

In the picturesque landscapes of Sardinia, Italy, lives a family that has etched its name in the annals of human longevity. The Melis siblings, a family of nine, hold the prestigious Guinness World Record for the highest combined age, summing up to a staggering 861 years. This extraordinary record, acknowledged in 2012, has put the spotlight on the familys way of life, and particularly, their dietary habits.

At the helm of this family is the eldest sister, Consolata Melis, who celebrates 109 years of life. On the other end of the spectrum is the youngest, Mafalda, a sprightly 78 at the time of the record. Its a longevity that isnt merely confined to them; it is a characteristic trait that reflects the extended lifespan of many Sardinian residents. The island is globally renowned for its high concentration of centenarians, and the Melis family is its shining testament.

So, what is their secret to a long, healthful life? The answer resides in the Melis familys kitchen. Their daily diet prominently features a traditional Sardinian soup known as Sardinia Minestrone. This hearty, three-bean soup, accompanied by sourdough bread and a modest glass of red wine, forms the staple of their meals. The Melis siblings attribute their remarkable ages to the regular consumption of this nourishing dish, a belief that is shared by many families across Sardinia.

The Melis siblings lifestyle offers an invaluable insight into the dietary patterns associated with longevity in Sardinia. Their consumption of Sardinia Minestrone is not merely a family tradition but a reflection of the common practices among the islands inhabitants known for their healthful and prolonged lives. Revealed by renowned author Dan Buettner in his exploration of lifestyle habits promoting longevity, the Melis dietary secret underscores the impact of diet on our overall health and lifespan.

Visit link:
The Melis Siblings: A Longevity Tale Rooted in Diet - BNN Breaking

Posted in Longevity | Comments Off on The Melis Siblings: A Longevity Tale Rooted in Diet – BNN Breaking

L’Oral Invests in Swiss Longevity Biotech Company – WWD

PARIS LOral has taken a minority stake in Swiss longevity biotech company Timeline.

Terms of the deal, which was made through the beauty giants strategic venture capital fund Business Opportunities for LOral Development, were not disclosed.

Timeline was founded in 2007 by Chris Rinsch and Patrick Aebischer as a spinoff of the Swiss Federal Institute of Technology. It develops solutions for longevity in the food, business and health categories.

Rinsch serves as Timeline president, and Aebischer is its chairman.

Timeline has developed a proprietary molecule, Mitopure, that recycles and rejuvenates aging mitochondria, the powerhouses of cells, LOral said in a statement Tuesday.This breakthrough technology is backed by more than a decade of research by distinguished scientists, multiple gold standard clinical studies and an unparalleled intellectual property portfolio. The investment will enable Timeline to further develop its unique technology and expand operations, while enabling future collaboration with LOral.

The beauty industrys lexicon and focus keep expanding. Health, then well-being, were buzzwords in the recent past. Now, with the convergence of those two and scientific advances, longevity is becoming a key talking point and market shapeshifter.

Longevity is about living healthier for longer,and LOral has been working for more than a decade to understand and anticipate what this could mean for beauty, said Barbara Lavernos, deputy chief executive officer and in charge ofresearch,innovation andtechnologyat LOral. Longevity adds a new dimension to beauty, focused on predicting, correcting and even reversing the aging of our skin, scalp and hair. Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty.

This strategic collaboration reflects the breakthrough multidimensional approach that weve always believed is necessary to make meaningful advancements for longevity and health span, Aebischer said.

BOLD has been ramping up its acquisition pace. On Jan. 9 it revealed it had acquired environmental water-tech start-up Gjosa. Investments for the venture capital fund last year included in Shinehigh Innovation and in Genomatica Inc., an initiative centered on developing, producing and commercializing biotechnology-based alternatives to key beauty product ingredients.

Go here to see the original:
L'Oral Invests in Swiss Longevity Biotech Company - WWD

Posted in Longevity | Comments Off on L’Oral Invests in Swiss Longevity Biotech Company – WWD

L’Oral Bets on Longevity Biotech Company Timeline – The Business of Fashion

On Tuesday, LOral Groupes venture capital arm, BOLD (Business Opportunities for LOral Development), announced an investment in Swiss consumer health company Timeline.

The $66 million Series D round was led by BOLD with participation from Nestl.

Founded in 2007, Timeline focuses on ageing and longevity with proprietary technology called Mitopure, which is incorporated into its line of supplements and topical skincare. The company will use its latest funding round for expansion across food, beauty and health sectors.

This strategic collaboration reflects the breakthrough multidimensional approach that weve always believed is necessary to make meaningful advancements for longevity and healthspan, said Patrick Aebischer, co-founder and chairman of Timeline.

Already an area of growing focus in the health and science fields, longevity biotech has gained more traction in beauty. In Dec. 2023, Este Lauder announced a new skin longevity platform in tandem with its latest Re-Nutriv face cream containing an ingredient born out of its research. In addition to conglomerates, longevity beauty startups such as OneSkin and Aramore, a brand founded by Stephen Kennedy Smith, President John F. Kennedy, Jr.s nephew, have come to market.

Longevity is about living healthier for longer and LOral has been working for a decade to understand and anticipate what this could mean for beauty ... Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty, said Barbara Lavernos, deputy chief executive officer in charge of research, innovation and technology at LOral.

Learn more:

Why Este Lauder Is Trying to Move Upmarket

A new Re-Nutriv launch from its namesake brand suggests a greater interest in the upper echelons of beauty.

Originally posted here:
L'Oral Bets on Longevity Biotech Company Timeline - The Business of Fashion

Posted in Longevity | Comments Off on L’Oral Bets on Longevity Biotech Company Timeline – The Business of Fashion

AMD talks AM5 APUs and AM4 longevity – PCWorld

CES is where the biggest players in tech strut their stuff and AMD is no exception. But the company had a surprise for us this year: new CPUs for the AM4 socket, still seemingly going strong after an incredible seven years of active support. AMDs Donny Woligroski, Technical Processing Marketing Manager for Desktop and Laptop Consumer Processors, took some time to talk to PCWorlds Adam Patrick Murray for our latest YouTube video.

On AM4 specifically, Woligroski said that the huge remaining installation base was a big part of the decision to continue supporting the platform with the new Ryzen 7 5700X3D and three other chips. The AM5 solution is for those who want to tee up for the future, he said, but AM4 will remain supported at least for the time being. When will the train stop? Possibly when the cost of producing (or even finding) the older DDR4 memory eclipses that of DDR5.

As for the AM5 socket, thats the home of AMDs latest and greatest consumer desktop chips, he says that market forces delayed the launch of the companys combined APU designs. That and the fact that Ryzen 7000 CPUs include more robust integrated graphics via the RDNA 2 architecture. But DDR5 unlocks greater graphics performance, so the new Ryzen 8000 series gets RDNA 3 integration. The most powerful of these chips, the Ryzen 7 8700 G, has access to a Radeon 780M graphics core.

What about the AI-boosting NPUs (Neural Processing Unit) built into some of AMDs laptop and now desktop chips? Why is it time to bet big on what seems to be a still-emerging use case? Like everything else in PC hardware its the chicken or the egg if you dont build the hardware, developers cant develop it.

For more interviews from CES and coverage of the latest in tech, be sure to subscribe to PCWorld on YouTube.

Read this article:
AMD talks AM5 APUs and AM4 longevity - PCWorld

Posted in Longevity | Comments Off on AMD talks AM5 APUs and AM4 longevity – PCWorld